Free Alerts   Login
Health Care › Services-Commercial Physical & Biological Research

MXCT Stock Price Correlated With MaxCyte Financials

MXCT Stock Price vs. Quarterly
MXCT
Income Statement
Cash Flow
Balance Sheet

MXCT Income Statement

Enable JavaScript and reload
Revenue, Net:
Revenue Per Share:
Cost of Goods & Services Sold:
Gross Profit:
Selling, General & Admin Expense:
Research & Development Expense:
Total Operating Expenses:
Operating Income:
Income Taxes:
Net Income:
Earnings Per Share, Diluted:
Earnings Per Share, Basic:
Shares Outstanding, Basic Avg:
Shares Outstanding, Diluted Avg:
Common Stock Shares Outstanding:

MXCT Cash Flow

Enable JavaScript and reload
Operating Activities Net Income:
Depreciation, Depletion & Amortization:
Change in Accounts Receiveable:
Net Cash from Operations:
Net Cash from Operations Per Share:
Repurchases/Buybacks Common Stock:
Issuance of Long-term Debt:
Cash Dividends Paid:
Net Cash from Financing Activities:
Property, Plant & Equipment Purchases:
Purchases of Businesses, Net of Cash:
Net Cash from Investing Activities:
Net Change in Cash & Equivalents:

MXCT Balance Sheet

Enable JavaScript and reload
Cash and Cash Equivalents:
Short-Term Investments:
Accounts Receivable, Net:
Inventories:
Total Current Assets:
Property, Plant & Equipment, Net:
Total Assets:
Accounts Payable:
Current Portion of Long-Term Debt:
Total Short-Term Liabilities:
Long Term Debt, Non-Current Portion:
Total Long-Term Liabilities:
Total Liabilities:

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Blackrock.
6,920,084 sh
105,002 sh
2%
$31,763
-$37,178,585
Vitruvian Partners
5,043,356 sh
 
$23,149
Vanguard Group
4,970,930 sh
82,457 sh
2%
$22,816
-$1,381
Casdin Capital
4,715,000 sh
-210,000 sh
-4%
$21,642
-$2,737
Stonepine Capital Management
3,966,916 sh
3,693,629 sh
1352%
$18,208
$16,716
Arrowmark Colorado Holdings
2,576,260 sh
277,186 sh
12%
$11,825
$445
Holocene Advisors, Lp
2,117,228 sh
 
$9,718
Massachusetts Financial Services /Ma/
1,949,375 sh
-18,866 sh
-1%
$8,948
-$795
Millennium Management
1,936,992 sh
-910,161 sh
-32%
$8,891
$8,877
Granahan Investment Management/Ma
1,891,888 sh
1,183,731 sh
167%
$8,684
$5,179
Blue Water Life Science Advisors
1,885,000 sh
-1,340,000 sh
-42%
$8,652
-$7,312
First Light Asset Management
1,857,566 sh
493,344 sh
36%
$8,526
$1,773
State Street
1,812,374 sh
18,225 sh
1%
$8,319
-$562
Geode Capital Management
1,794,652 sh
115,276 sh
7%
$8,237
-$76
American Century Companies
1,708,861 sh
23,670 sh
1%
$7,844
-$480
Portolan Capital Management
1,649,877 sh
1,028,263 sh
165%
$7,573
$4,496
Morgan Stanley
1,622,017 sh
-58,852 sh
-4%
$7,445
-$875
River & Mercantile Asset Management Llp
1,542,743 sh
-165,605 sh
-10%
$7,031
-$1,374
Grandeur Peak Global Advisors
1,378,548 sh
186,743 sh
16%
$6,328
-$179
Ameriprise Financial
1,319,739 sh
-9,826 sh
-1%
$6,058
-$523

Free historical financial statements for MaxCyte Inc.. See how revenue, income, cash flow, and balance sheet financials have changed over 9 quarters since 2021. Compare with MXCT stock chart to see long term trends.

Data imported from MaxCyte Inc. SEC filings. Check original filings before making any investment decision.